KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

ClearPoint Neuro (CLPT) Leases (2019 - 2025)

ClearPoint Neuro's Leases history spans 7 years, with the latest figure at $6.0 million for Q3 2025.

  • For Q3 2025, Leases rose 85.51% year-over-year to $6.0 million; the TTM value through Sep 2025 reached $6.0 million, up 85.51%, while the annual FY2024 figure was $3.1 million, 13.41% down from the prior year.
  • Leases for Q3 2025 was $6.0 million at ClearPoint Neuro, down from $6.1 million in the prior quarter.
  • Across five years, Leases topped out at $6.1 million in Q2 2025 and bottomed at $1.8 million in Q1 2023.
  • The 5-year median for Leases is $3.0 million (2025), against an average of $3.1 million.
  • The largest annual shift saw Leases surged 702.83% in 2021 before it dropped 21.1% in 2022.
  • A 5-year view of Leases shows it stood at $2.2 million in 2021, then decreased by 15.44% to $1.9 million in 2022, then soared by 88.07% to $3.6 million in 2023, then fell by 13.41% to $3.1 million in 2024, then skyrocketed by 92.97% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Leases are $6.0 million (Q3 2025), $6.1 million (Q2 2025), and $3.0 million (Q1 2025).